Endoscopic Treatment of Gastric Neuroendocrine Tumors: What's Next?
作者信息
Kim Ilsoo, Cho Yu Kyung
机构信息
Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Gut Liver. 2025 Mar 15;19(2):148-150. doi: 10.5009/gnl250107.
Abstract
摘要
相似文献
1
Endoscopic Treatment of Gastric Neuroendocrine Tumors: What's Next?胃神经内分泌肿瘤的内镜治疗：下一步何去何从？
Gut Liver. 2025 Mar 15;19(2):148-150. doi: 10.5009/gnl250107.
2
Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?胰腺神经内分泌和类癌肿瘤：新的、旧的和不同的是什么？
Curr Oncol Rep. 2012 Jun;14(3):249-56. doi: 10.1007/s11912-012-0232-1.
3
PTSD Treatment for Veterans: What's Working, What's New, and What's Next.退伍军人创伤后应激障碍的治疗：哪些方法有效、有哪些新进展以及后续方向
P T. 2016 Oct;41(10):623-634.
4
Future Hospital Commission - 10 years on. What's changed, what's new and what's next?未来医院委员会——十年之后。有哪些变化、有哪些新情况以及接下来会怎样？
Future Healthc J. 2024 Jul 12;11(2):100155. doi: 10.1016/j.fhj.2024.100155. eCollection 2024 Jun.
5
Binge eating disorder revisited: what's new, what's different, what's next - Addendum.暴饮暴食症再探讨：新变化、差异及未来走向——附录
CNS Spectr. 2019 Aug;24(S1):82. doi: 10.1017/S1092852919001366.
6
Dental software: what's hot, what's not, what's next.牙科软件：热门、冷门与未来走向
Dent Today. 2000 Apr;19(4):102, 104.
7
PET Radiopharmaceuticals: What's new, what's reimbursed, and what's next?正电子发射断层显像（PET）放射性药物：有哪些新进展、哪些已获报销以及后续发展如何？
J Nucl Med Technol. 2018 Feb 2. doi: 10.2967/jnmt.117.205021.
8
Translational research in neuroendocrine tumors (NETs): What's new in 2021?神经内分泌肿瘤（NETs）的转化研究：2021年有哪些新进展？
Ann Endocrinol (Paris). 2022 Dec;83(6):469-471. doi: 10.1016/j.ando.2022.09.001. Epub 2022 Oct 3.
9
A commentary on the evolution of NIH: what's in, what's out, what's hot, what's not.关于美国国立卫生研究院发展历程的述评：哪些入选，哪些落选，哪些热门，哪些冷门。
Integr Physiol Behav Sci. 1998 Apr-Jun;33(2):115-7. doi: 10.1007/BF02688652.
10
Diagnosis and management of benign secreting pancreatic insulinoma: What's new? 4 case report.良性分泌性胰腺胰岛素瘤的诊断与管理：有哪些新进展？4例病例报告。
Rare Tumors. 2025 Jan 8;17:20363613241313409. doi: 10.1177/20363613241313409. eCollection 2025.
本文引用的文献
1
Clinical Characteristics and Long-term Outcomes of Gastric Neuroendocrine Tumors.胃神经内分泌肿瘤的临床特征与长期预后
Gut Liver. 2025 Mar 15;19(2):189-197. doi: 10.5009/gnl240272. Epub 2025 Jan 3.
2
Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.1 型胃神经内分泌肿瘤的治疗：一项 11 年回顾性单中心研究。
BMC Gastroenterol. 2023 Dec 14;23(1):440. doi: 10.1186/s12876-023-03079-6.
3
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3.欧洲神经内分泌肿瘤学会（ENETS）2023 年胃十二指肠神经内分泌肿瘤（NETs）G1-G3 指导意见。
J Neuroendocrinol. 2023 Aug;35(8):e13306. doi: 10.1111/jne.13306. Epub 2023 Jul 4.
4
Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs.胃神经内分泌肿瘤（g-NETs）：3型g-NETs管理与结局的系统评价
Cancers (Basel). 2023 Apr 8;15(8):2202. doi: 10.3390/cancers15082202.
5
Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016.胃肠道神经内分泌肿瘤患者的发病率和生存率趋势：一项1977 - 2016年的监测、流行病学和最终结果（SEER）数据库分析
Front Oncol. 2023 Jan 26;13:1079575. doi: 10.3389/fonc.2023.1079575. eCollection 2023.
6
The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5.世界卫生组织胃肠道神经内分泌肿瘤新分类以及生长抑素受体2和5的免疫组化表达
Exp Ther Med. 2021 Oct;22(4):1179. doi: 10.3892/etm.2021.10613. Epub 2021 Aug 13.
7
Endoscopic mucosal resection: still a reliable therapeutic option for gastrointestinal neuroendocrine tumors.内镜黏膜下剥离术：胃肠道神经内分泌肿瘤的可靠治疗选择。
BMC Gastroenterol. 2021 May 24;21(1):238. doi: 10.1186/s12876-021-01821-6.
8
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.长期使用质子泵抑制剂的患者发生的胃神经内分泌肿瘤为惰性肿瘤，预后良好。
Histopathology. 2020 Dec;77(6):865-876. doi: 10.1111/his.14220. Epub 2020 Sep 20.
9
Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.韩国胃肠胰神经内分泌肿瘤的发病率及临床特征：单中心经验
Korean J Intern Med. 2017 May;32(3):452-458. doi: 10.3904/kjim.2015.232. Epub 2016 Mar 29.
10
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).胃肠胰神经内分泌（包括类癌）肿瘤（NETs）管理指南。
Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3.
Zotero 插件